Nimbus Discovery, LLC, a Cambridge-based biotechnology company, announced an agreement with Shire plc to co-develop small molecule therapies for several rare genetic diseases known as lysosomal storage disorders. may8 2013
read at
http://bostonherald.com/business/healthcare/2013/05/nimbus_discovery_shire_reach_deal_to_co_develop_drugs
No comments:
Post a Comment